Get the tools used by (smart)2 investors.
Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

500124: Dr Reddy’s Laboratories Ltd

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active In...

1,144.05 INR
Price
INR
Fair Value
Upside
1,093.00 - 1,420.20
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Dr Reddy’s Laboratories Ltd's Revenue:

Mar 2016Mar 2018Mar 2020Mar 2022Mar 2024150 B200 B250 B300 B

Performance Summary
  • Dr Reddy’s Laboratories's latest twelve months revenue is 311.3 billion
  • Dr Reddy’s Laboratories's revenue for fiscal years ending March 2020 to 2024 averaged 220.8 billion.
  • Dr Reddy’s Laboratories's operated at median revenue of 214.4 billion from fiscal years ending March 2020 to 2024.
  • Looking back at the last 5 years, Dr Reddy’s Laboratories's revenue peaked in December 2024 at 311.3 billion.
  • Dr Reddy’s Laboratories's revenue hit its 5-year low in March 2020 of 174.6 billion.
  • Dr Reddy’s Laboratories's revenue increased in each of the last 5 fiscal years from 174.6 billion in 2020 to 279.2 billion in 2024.

How does Dr Reddy’s Laboratories's Revenue benchmark against competitors?

Hide this widget

Metric Usage: Revenue

Hide this widget
total_rev
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Revenue in the financials category include:

  • Total Operating Leases - The sum of all operating leases.
  • As Reported, Operating Income - This item represents the operating income or operating profit as reported by the company in its financial statement.
  • Other Non-Current Liabilities - Field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Total Debt Repaid - This item is the sum of following components: Capital Lease Payments, Trust Preferred Securities Repaid, Short Term Debt Repaid, and Long-Term Debt Repaid.
View Full List

Search for metric or datapoint

Revenue

The revenue metric captures the total income generated by a company from its core operational activities

Definition of Revenue

Hide this widget

Dr. Reddy’s Laboratories reported revenue of 311.3 B for the latest twelve months ending December 31, 2024 on its income statement.

The tables below summarises Dr. Reddy’s Laboratories’s Revenue over the last five years:

Fiscal Year Revenue
2020-03-31 174.6 B
2021-03-31 189.7 B
2022-03-31 214.4 B
2023-03-31 245.9 B
2024-03-31 279.2 B

The tables below summarizes Dr. Reddy’s Laboratories’s Revenue over the last four quarters:

Quarter Ending Revenue
2024-03-31 70.83 B
2024-06-30 76.727 B
2024-09-30 80.162 B
2024-12-31 83.586 B

Click the link below to download a spreadsheet with an example Revenue calculation for Dr Reddy’s Laboratories Ltd below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
9.587 B89.587 B169.6 B325.9 B050100150

The chart above depicts the distribution of revenue for companies operating in the Healthcare sector in the Developing economic region. Over 1,180 companies were considered in this analysis, and 1,134 had meaningful values. The average revenue of companies in the sector is 25.196 B with a standard deviation of 45.82 B.

Dr Reddy’s Laboratories Ltd's Revenue of 311.3 B ranks in the 99.7% percentile for the sector. The following table provides additional summary stats:

Revenue In The Healthcare Sector
Economic Risk RegionDeveloping
Total Constituents1,182
Included Constituents1,134
Min35.893 M
Max325.6 B
Median8.564 B
Mean25.196 B
Standard Deviation45.82 B

You can find companies with similar revenue using this stock screener.

All rights reserved. Terms Of Use